Hemophilia Clinical Trials

A listing of 3 Hemophilia clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Hemophilia

1 - 3 of 3

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 3 active clinical trials seeking participants for Hemophilia research studies. The states with the highest number of trials for Hemophilia participants are California, Ohio, Texas and New York.

Featured Therapy

Unique Treatment for High Blood Pressure

Worried about high blood pressure? Think beyond typical high blood pressure treatments.

People who may be candidates for this procedure:

• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹

Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.

¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.

Conditions:

High Blood Pressure

High Blood Pressure (& [Essential Hypertension])

High Blood Pressure (Hypertension).

Hypertension

Essential Hypertension

Learn More

Featured Offer

Discover Affordable Semaglutide Providers

We Checked the Checkout Page on Every Semaglutide Provider. Here's What We Found.
There's a big difference between the price on a landing page and what you actually pay. We went all the way through checkout so you know exactly what to expect.

📋 5 providers ranked by true monthly cost
💵 Options starting as low as $149/month
🏥 Only licensed providers using FDA-registered pharmacies
⭐ Real Trustpilot scores included — including the ones with mixed reviews
🔒 Includes cancellation policy warnings so you don't get stuck

Conditions:

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

NCT06345833

Recruiting

Tranexamic acid (TXA) is a fibrinolytic inhibitor which prevents prolonged bleeding by interfering with fibrin clot breakdown by competitively binding to lysine receptors on plasminogen; this prevents the conversion of plasminogen to plasmin. TXA will be applied to a randomly assigned side of the face during facelift surgery. The intervention groups will include 1% TXA mixed with standard local consisting 1/4% lidocaine with 1:100,000 epinephrine, 3% TXA on TXA-soaked pledgets applied for 10 min... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: University of Minnesota, Minneapolis, Minnesota

Conditions: Hemophilia, Hemorrhage, Facelift Surgery

Learn More ›

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628

Recruiting

In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and acquired hematologic conditions, not just those for bleeding and clotting disorders, is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have yet to demonstrate long-term safety and effectiveness beyond the pivotal trials that led to their approval. In addition, results from well-controlled, pivotal studies often cannot be replicated once a therapy has been approved for general use.(1,2,3,4) In 2019 alone, the United States Food and Drug Administration (FDA) has issued approvals for twenty-four new therapies for congenital and acquired hematologic conditions.(5) In addition, almost 10,000 new studies for hematologic diseases are currently registered on www.clinicaltrials.gov.(6) With this increase in potential new therapies on the horizon, it is imperative that clinicians and clinical researchers in the field of non-neoplastic hematology have a uniform, secure, unbiased, and enduring method to collect long-term safety and efficacy data. ATHN Transcends is a cohort study to determine the safety, effectiveness, and practice of therapies used in the treatment of participants with congenital or acquired non-neoplastic blood disorders and connective tissue disorders with bleeding tendency. The study consists of 7 cohorts with additional study "arms" and "modules" branching off from the cohorts. The overarching objective of this longitudinal, observational study is to characterize the safety, effectiveness and practice of treatments for all people with congenital and acquired hematologic disorders in the US. As emphasized in a recently published review, accurate, uniform and quality national data collection is critical in clinical research, particularly for longitudinal cohort studies covering a lifetime of biologic risk.(7) Read Less

Gender:

ALL

Ages:

All

Trial Updated:

03/26/2025

Locations: Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital, Phoenix, Arizona +72 locations

Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital, Phoenix, Arizona

Arkansas Center for Bleeding Disorders, Little Rock, Arkansas

Orthopaedic Institute for Children HTC, Los Angeles, California

Childrens Hospital Los Angeles, Los Angeles, California

UCSF Benioff Children's Hospital Oakland, Oakland, California

University of California at Davis Hemophilia Treatment Center, Sacramento, California

Loma Linda Hemoglobinopathy and Inherited Bleeding Disorder Program, San Bernardino, California

Hemophilia & Thrombosis Treatment Center at UC San Diego Health, San Diego, California

Rady Children's Hospital San Diego, San Diego, California

University of California, San Francisco Hemophilia & Thrombosis Center, San Francisco, California

University of Colorado Denver Hemophilia and Thrombosis Center, Aurora, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Yale Hemophilia Treatment Center, New Haven, Connecticut

Delaware Hemophilia Treatment Center, Wilmington, Delaware

Georgetown University, Washington, District of Columbia

Children's National Hemophilia Center, Washington, District of Columbia

University of Florida Hemophilia Treatment Center, Gainesville, Florida

University of Miami Comprehensive Hemophilia Treatment Center, Miami, Florida

Arnold Palmer Hospital for Children - The Haley Center for Children's Cancer and Blood Disorders, Orlando, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

St. Joseph's Hospital Center for Bleeding & Clotting Disorders, Tampa, Florida

Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia

Emory/Children's Health Care of Atlanta, Atlanta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

Rush University Medical Center, Chicago, Illinois

Bleeding and Clotting Disorders Institute, Peoria, Illinois

Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana

Iowa Hemophilia and Thrombosis Center, Iowa City, Iowa

Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans, Louisiana

Maine Hemophilia and Thrombosis Center, Scarborough, Maine

Johns Hopkins University Hemophilia Treatment Center, Baltimore, Maryland

Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center, Boston, Massachusetts

Central Michigan Children's Hospital of Michigan, Detroit, Michigan

Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit, Michigan

Mayo Comprehensive Hemophilia Center, Rochester, Minnesota

Children's Mercy Hospital - Kansas City, Kansas City, Missouri

The John Bouhasin Center for Children with Bleeding Disorders, Saint Louis, Missouri

Cure 4 The Kids Foundation, Las Vegas, Nevada

Hemostasis and Thrombosis Center of Nevada, Reno, Nevada

Newark Beth Israel Medical Center - Hemophilia Center, Newark, New Jersey

University of New Mexico Ted R. Montoya Hemophilia & Thrombosis Program, Albuquerque, New Mexico

Montefiore Medical Center, Bronx, New York

Western New York BloodCare, Buffalo, New York

Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park, New York

Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York

American Thrombosis and Hemostasis Network, Rochester, New York

Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital, Charlotte, North Carolina

East Carolina University Hemophilia Treatment Center, Greenville, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati, Ohio

University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati, Ohio

University Hospitals Health System Cleveland, Cleveland, Ohio

Nationwide Children's Hospital Columbus, Columbus, Ohio

Dayton Children's Hemostasis and Thrombosis Center, Dayton, Ohio

Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital, Toledo, Ohio

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania

Rhode Island Hospital Hemostasis and Thrombosis Center, Providence, Rhode Island

St. Jude Children's Research Hospital, Memphis, Tennessee

Vanderbilt University Medical Center, Nashville, Tennessee

Children's Blood and Cancer Center of Central Texas, Austin, Texas

North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas, Texas

North Texas Comprehensive Hemophilia Treatment Center, Dallas, Texas

Fort Worth Bleeding Disorders Program, Fort Worth, Texas

Gulf States Hemophilia and Thrombophilia Center, Houston, Texas

Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston, Texas

South Texas Comprehensive Hemophilia and Thrombophilia Treatment Center, San Antonio, Texas

Washington Center for Bleeding Disorders, Seattle, Washington

Hemophilia Outreach Center Green Bay, Green Bay, Wisconsin

Comprehensive Center for Bleeding Disorders, Milwaukee, Wisconsin

Conditions: Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder, Hemophilia, Thrombosis, Von Willebrand Diseases, Thrombophilia, Rare Bleeding Disorder, Platelet Disorder, Factor IX Deficiency, Factor VIII Deficiency, Thalassemia, Sickle Cell Disease

Learn More ›

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT04278404

Recruiting

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Gender:

ALL

Ages:

Between 0 years and 20 years

Trial Updated:

03/11/2025

Locations: Phoenix Children's Hospital, Phoenix, Arizona +50 locations

Phoenix Children's Hospital, Phoenix, Arizona

Arkansas Children's Hospital Research Institute, Little Rock, Arkansas

University of California, Los Angeles Medical Center, Los Angeles, California

Lucile Packard Children's Hospital, Palo Alto, California

Colorado University Denver, Aurora, Colorado

The Children's Hospital Colorado, Aurora, Colorado

Alfred I. DuPont Hospital for Children, Wilmington, Delaware

University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida

Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii

Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois

Riley Hospital for Children at Indiana University, Indianapolis, Indiana

University of Iowa Stead Family Children's Hospital, Iowa City, Iowa

University of Kansas Medical Center-JG Kidney Institute, Kansas City, Kansas

University of Louisville Norton Childrens Hospital, Louisville, Kentucky

Tulane University Health Science Center, New Orleans, Louisiana

Ochsner Baptist Clinical Trials Unit, New Orleans, Louisiana

University of Maryland Medical Center, Baltimore, Maryland

Boston Children's Hospital, Boston, Massachusetts

Massachusetts General Hospital, Lexington, Massachusetts

University of Minnesota, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Mississippi Center for Advanced Medicine, Madison, Mississippi

Children's Mercy Hospital, Kansas City, Missouri

University of Nebraska Medical Center, Omaha, Nebraska

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

University of New Mexico Health Science Center, Albuquerque, New Mexico

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Duke University Health System, Durham, North Carolina

Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio

Board of Regents of the University of Oklahoma, Oklahoma City, Oklahoma

Oregon Health and Science University, Portland, Oregon

Pennsylvania State University--Hershey Children's Hospital, Hershey, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Medical University of South Carolina Children's Hospital, Charleston, South Carolina

University of South Carolina, Columbia, South Carolina

Avera McKennan Hospital & University Medical Center, Sioux Falls, South Dakota

Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee

Dell Children's Medical Center of Central Texas, Austin, Texas

University of Texas-Southwestern Medical Center Dallas, Dallas, Texas

University of Texas--Memorial Hermann Texas Medical Center, Houston, Texas

The Womens Hospital of Texas, Houston, Texas

University of Utah, Salt Lake City, Utah

Seattle Children's Hospital, Seattle, Washington

West Virginia University Hospital, Morgantown, West Virginia

University of Wisconsin, Madison, Wisconsin

University Wisconsin Madison, Madison, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

The Hospital for Sick Children, Toronto, Ontario

CHU Sainte-Justine, Montréal, Quebec

Conditions: Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema, Hypokalemia, Heart Failure, Menorrhagia, Insomnia, Pneumonia, Skin Infection, Arrythmia, Asthma in Children, Bronchopulmonary Dysplasia, Adrenal Insufficiency, Fibrinolysis; Hemorrhage, Hemophilia, Attention Deficit Hyperactivity Disorder, Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coagulation Disorder, Down Syndrome

Learn More ›

1 - 3 of 3